Sekyi-Brown Reginald: Ghana Should Include Alteplase and Tenecteplase in National Health Insurance
Sekyi-Brown Reginald, Chairperson at Early Career Pharmaceutical Group, Ghana, Franchise Manager at Pharmasymbiosis, shared on LinkedIn about a recent article by Samuel Darkwah et al, published in Stroke Research and Treatment:
”Rethinking Emergency Medicine in Ghana
Darkwah et al intimate that Stroke ranks amongst the top 3 causes of death and disability in Ghana in their 2025 situational analysis of Stroke in Ghana.
Ghana has to seriously consider including alteplase/tenecteplase in its National Health Insurance List.
Given the fact that it has been part of the World Health Organization’s Essential medicines list since 2019.
Although the current NHIS list captures Streptokinase; the evolution of medicine requires that our Essential Medicines List reflects the reality of modern clinical practice.
Even more importantly, the new STROKE guideline prominently recommends Alteplase and Tenecteplase makes it even more timely.
For a country that spends millions on healthcare; making a conscious effort to include such critical medicines is long overdue.”
Title: Stroke in Ghana: A Situational Analysis
Authors: Samuel Darkwah, Aaron Awere-Duodu, Bismark Opoku-Asare, Eric S. Donkor
Read the Full Article on Stroke Research and Treatment
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan